ArticlePharmacology2022
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma.
David König et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticlePharmacology2022
David König et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.